Health Catalyst, Inc. (HCAT) › Cash & EquivalentsHealth Catalyst, Inc. (HCAT) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2018: $28.43M2019: $18.03M2020: $91.95M2021: $193.23M2022: $116.31M2023: $106.28M2024: $249.65M2025: $50.81M$50.81M2018Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$50.81M-79.6%2024$249.65M+134.9%2023$106.28M-8.6%2022$116.31M-39.8%2021$193.23M+110.1%2020$91.95M+409.9%2019$18.03M-36.6%2018$28.43M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share